meitshel

ATRA -long- catalyst play

شراء
meitshel تم تحديثه   
NASDAQ:ATRA   Atara Biotherapeutics, Inc.
developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

This is not a financial advice!

Upcoming catalysts 06/30/2024 and 06/30/2025

Block buys recently and passive stakes

Rel. Vol. on 03/08/2024 at 4.32

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Keep an eye on 1.0 / 1.2 / 1.4 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 0.5 (very tight)

TPs approx. 2.0 maybe even 5.7

Most info on the chart.

Trade carefully!
تعليق:
Atara Biotherapeutics, Inc. Passive Stake (FormSC13G)
إخلاء المسؤولية

لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.